NASDAQ: ASNDAscendis Pharma A Stock Forecast, Predictions & Price Target
Analyst price target for ASND
Based on 8 analysts offering 12 month price targets for Ascendis Pharma A.
Min Forecast
$0.40-99.56%
Avg Forecast
$114.80+25.97%
Max Forecast
$192.00+110.69%
Should I buy or sell ASND stock?
Based on 8 analysts offering ratings for Ascendis Pharma A.
Strong Buy
Strong Buy
4 analysts 50%
Buy
2 analysts 25%
Hold
2 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Be the first to know when Wall Street analysts revise their ASND stock forecasts and price targets.
ASND stock forecasts by analyst
| Analyst / Firm | Rating | Action | Price Target | Upside/Downside | Date | Analyst Color |
|---|---|---|---|---|---|---|
| Strong Buy | Reiterates | $152.00 | +66.79% | 2023-09-15 | ||
| Strong Buy | Maintains | $134.00 | +47.04% | 2023-09-06 | ||
| Buy | Maintains | $192.00 | +110.69% | 2023-09-06 | ||
| Hold | Maintains | $113.00 | +24.00% | 2023-09-06 | ||
| Hold | Assumes | $89.00 | -2.34% | 2023-06-14 | ||
| Buy | Maintains | $0.40 | -99.56% | 2023-04-18 | ||
| Strong Buy | Maintains | $146.00 | +60.21% | 2023-04-05 | ||
| Strong Buy | Maintains | $92.00 | +0.95% | 2023-04-04 |
Forecast return on equity
Is ASND forecast to generate an efficient return?
Company
N/A
Industry
0.66%
Market
28.71%
Forecast return on assets
Is ASND forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%
ASND revenue growth forecast
How is ASND forecast to perform vs Biotechnology companies and vs the US market?
Company
75.3%
Industry
34.31%
Market
8.24%
ASND's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ASND's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast
ASND vs Biotech Stocks
Ascendis Pharma A Stock Forecast FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.